Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,028.00    14.00 (1.38%)
Bid:
1,030.00
Ask:
1,031.00
Spread: 1.00 (0.097%)
Market Cap: £5.03b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Directorate Change

21 Dec 2017 07:00

RNS Number : 9509Z
Babcock International Group PLC
21 December 2017
Β 

Β 

21 December 2017

Β 

Babcock International Group PLC (Babcock or the Group)

Directorate change: Bill Tame to retire

Β 

Babcock today announced that Bill Tame, Chief Executive Global Growth and Operations, will retire from the Group on 30 June 2018. Bill joined Babcock as Group Finance Director in January 2001. During his 16 years at the Company, Babcock has grown from a small cap business to a leading engineering services company, with a turnover of Β£5.2 billion in 2016/17.

Β 

Babcock Chairman, Mike Turner, said:

Β 

"The Board thanks Bill for his commitment to Babcock over the last 16 years. Bill has been a key member of the leadership team during our transformation from a small cap business to a leading engineering services company. All of us wish him the very best for his retirement."

Β 

Bill Tame said:

Β 

"It has been a privilege to have been part of such a great success story. Babcock is a unique company and I am proud of what we achieved together. I wish the company continued success."

Β 

S430(2B) Companies Act 2006

Β 

Pending his retirement on 30 June 2018, Bill Tame will continue to be remunerated up to his date of leaving, in accordance with his contractual entitlements and the Company's directors' remuneration policy as approved by shareholders on 13 July 2017. Bill will not be eligible for a salary increase for 2018/19, nor will he receive a 2018 grant under the Company's 2015 Performance Share Plan (PSP), although he will be eligible for a time pro-rated bonus for the financial year 2018/19.

Β 

Details of the remuneration and the extent to which any of it will fall due for payment after Bill has ceased to be a director will be disclosed in the Directors' Remuneration Report that will form part of the Company's Annual Report and Accounts to be published in June 2018, and will also then be made available on the Company's website.

The Remuneration Committee has exercised its discretion and determined that Bill will be treated as a 'good leaver'. Outstanding share awards that he currently holds will, accordingly, be treated consistently with the terms of the Company's directors' remuneration policy, as follows:

Β 

Β· The 2015 PSP grant (over 52,193 shares) will vest on the normal vesting date in accordance with the PSP rules, subject to the achievement of the performance conditions attached to them. A cash sum equivalent to the dividends that accrue on the shares that vest will also be paid.

Β 

Β· The 2015 Deferred Bonus Matching Plan (DBMP) basic grant (over 16,070 shares) and basic matching grant (over 32,140 shares) will vest on the normal vesting date, in accordance with the DBMP rules. The extent to which the basic matching grant shall vest will be determined by the extent to which the performance conditions attached to the grant have been met over the performance period. A cash sum equivalent to the dividends that accrue on the shares that vest will also be paid.

Β 

The vesting periods for these awards will have been completed by Bill's date of retirement and, therefore, the performance-based awards will not be pro-rated for time.

Β 

Β· Outstanding Deferred Bonus Plan (DBP) grants made in 2016 (over 12,498 shares) and 2017 (over 12,519 shares) shall vest on their normal vesting dates, in accordance with the DBP rules. A cash sum equivalent to the dividends that accrue on the shares that vest will also be paid. To the extent that Bill receives a bonus for the financial year 2017/18 and for 2018/19, 40% of any such bonus will be deferred into the DBP.

Β 

Β· Bill will also retain an interest in the PSP grants made in 2016 (over 84,238 shares) and 2017 (over 96,112 shares). These interests will be pro-rated for time to the date of leaving, and will vest (to the extent the performance conditions attaching to the awards are met) on their normal vesting date, in accordance with the PSP rules. A cash sum equivalent to the dividends that accrue on any shares that vest will also be paid. The two-year post‑vesting holding period will continue to apply to any shares that vest under the 2017 PSP grant. As stated above, Bill will not receive a 2018 PSP grant.

Β 

No payments fall to be made to Bill by way of compensation for loss of office.

Β 

Β 

Ends

Β 

Enquiries

Β 

Babcock International Group PLC

020 7355 5300

Franco Martinelli

Kate Hill

FTI Consulting

020 3727 1340

Andrew Lorenz

Nick Hasell

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOAGMMZZZGMGNZM
Date   Source Headline
13th May 20267:00 amRNSFY26 post close trading update
1st May 20264:46 pmRNSTotal Voting Rights
1st May 20262:39 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares - Replacement
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:46 pmRNSTotal Voting Rights
1st Apr 202612:32 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSBabcock announces FMSP contract bridging agreement
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 202610:14 amRNSTransaction in Own Shares
13th Mar 202610:14 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20264:57 pmRNSEuro Medium Term Note Programme
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202611:33 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.